| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.06 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.06 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |